All News
Integra LifeSciences Announces Key Executive Appointments
Rebuilding Recovery: A Collaborative Approach to Complex Wound Healing
Strengthening Outcomes Together: A Conversation with Two Brothers at Integra LifeSciences
Innovation at Work
Integra LifeSciences Announces Leadership Transition
Stuart M. Essig, chairman of Integra’s Board of Directors, has been appointed president and chief executive officer, effective May 1, 2026. Mr. Essig will continue to serve as chairman. He succeeds Mojdeh Poul who is pursuing other opportunities. Integra also announced that Michael McBreen, currently executive vice president, president, Codman Specialty Surgical, has been appointed chief commercial officer.
Integra LifeSciences Reports First Quarter 2026 Financial Results
Integra LifeSciences reported financial results for the first quarter ending March 31, 2026.
World Health Starts with Innovation
Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization
Maria Cristina Fernandez-Gonzalez Named a 2026 Luminary by Healthcare Businesswomen’s Association (HBA)
A Steady Hand Behind Every Event
Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
Integra LifeSciences reported financial results for the fourth quarter and full year ended December 31, 2025.
